Opgen INC 8-K filings

CapForce Inc., formerly OpGen, Inc., announced stockholder approval of its new corporate name, a 2026 Incentive Compensation Plan, and key corporate governance matters, signaling a strategic pivot to fintech-enabled investment banking.

OpGen, Inc. has completed the acquisition of Sun Investment Enterprises Limited, gaining full ownership of fintech platform iCapX Sdn. Bhd. for $12.3 million paid in common stock, and secured an estimated $14 million advisory fee from a client.

OpGen, Inc. announced an extension of its equity financing agreement with AEI Capital Ltd. until December 31, 2026, alongside the resignation of President David Lazar effective January 8, 2026.

OpGen, Inc. announced the appointment of Christian-Laurent Bonte as its new Chief Executive Officer, succeeding John Tan Honjian who will continue as Chairman of the Board.

OpGen, Inc. announced the resignation of director Christian-Laurent Benoit Bonte, who will transition to lead the Digital Investment Banking Arm of its wholly-owned subsidiary, CapForce International Holdings Ltd.

OpGen, Inc. is strategically repositioning itself into the digital investment banking industry through its wholly-owned subsidiary, CapForce International Holdings Ltd., which has acquired an IPO advisory mandate and formed a joint venture with European Credit Investment Bank.

OpGen Inc. will be delisted from the Nasdaq Capital Market after the Nasdaq Listing Council upheld a previous decision, despite the company briefly regaining compliance with minimum stockholders' equity requirements.

OpGen, Inc. has appointed Mohd Azham Azudin as Chief Operating Officer and Gillian Tan Rou Yee as Company Secretary, effective December 4, 2024.

OpGen, Inc. has amended its agreement with AEI Capital Ltd., increasing potential funding to $9 million and extending the share purchase period to December 31, 2025.

OpGen, Inc. has entered into a securities purchase agreement for up to $3 million in financing while facing a potential delisting from the Nasdaq Capital Market.

OpGen Inc. announced it will restate its Q1 2024 financial statements due to an error in accounting for a lease indemnification asset.

OpGen, Inc. has appointed five new directors to its board, effective August 9, 2024, bringing diverse expertise in finance, investment, and technology.

OpGen Inc. sees a significant shift in leadership and ownership as AEI Capital Ltd. acquires a controlling stake, leading to the resignation of the CEO and board members.

OpGen, Inc. has regained compliance with Nasdaq's minimum bid price rule but is now facing a delisting notice due to not meeting the minimum stockholders' equity requirement.

OpGen, Inc. has been granted an extension by the Nasdaq Hearings Panel to file its overdue Form 10-Q by July 8, 2024, to maintain its listing.

OpGen Inc. has amended its previous 8-K filing to disclose the committee appointments of its newly elected board members, effective May 23, 2024.

OpGen, Inc. received a notice from Nasdaq regarding its failure to file its quarterly report, adding to existing non-compliance issues and increasing the risk of delisting.

OpGen, Inc. has announced a 1-for-10 reverse stock split to regain compliance with Nasdaq listing requirements and has amended its settlement agreement with the European Investment Bank to extend payment deadlines.

OpGen Inc. has amended its Series E Preferred Stock terms to remove ownership limitations and approved a reverse stock split at a special meeting of stockholders.

OpGen, Inc. has agreed to sell its Unyvero customer contracts and installed base to Camtech Pte Ltd for $218,000, marking a significant step in its strategic shift.

OpGen, Inc. has announced the resignation of UHY LLP as its independent auditor and the engagement of Beckles & Co. as its new auditor, effective April 23, 2024.

OpGen, Inc. received a notice from Nasdaq for failing to file its annual report, adding to existing concerns about its share price and increasing the risk of delisting.

OpGen, Inc. has appointed David Lazar as its new Chief Executive Officer, effective April 1, 2024, with a base salary of $406,000 per annum, deferred until the company has sufficient liquidity.

OpGen, Inc. has announced a $3 million investment from David E. Lazar, who will also become the new CEO, alongside a newly appointed board of directors.

OpGen, Inc. has been granted an extension until June 3, 2024, by the Nasdaq Hearings Panel to regain compliance with the minimum bid price requirement.

OpGen, Inc. has extended the exercise period for existing warrants to April 30, 2024, potentially increasing the company's capital through further warrant exercises.